A. FINCH Fletcher and Huehns to suggest differences in the behavior of the two iron-binding sites of the transferrin molecule. To clarify the continued controversy relating to this hypothesis, the original studies employing control plasma labeled with radioiron and the same plasma preincubated with reticulocytes were reexamined.
Regardless of whether human or rabbit plasma was employed, there was a considerably higher uptake from the control plasma. Isoelectric focusing procedures and electrophoresis in urea gels revealed that the conspicuous difference in the amount of iron uptake is the result of differences in the proportion of di-to monoferric transferrin in the two plasmas and the competitive advantage of the diferric moiety. These studies provide an explanation for the Fletcher-Huehns phenomenon without invoking functional differences between the two sites for iron on the transferrin molecule.
iron metabolism; transferrin; diferric vs. monoferric iron   THE PLASMA  IRON  TRANSPORT protein, transferrin, mediates iron exchange between body tissues (1, 2, 19) . The molecule has two iron-binding sites, which differ in their chemical behavior in most species (1, 2, 15, 19, 20) . A highly controversial question is whether this different chemical behavior is of any functional significance for tissue distribution in vivo. In 1967, hypothesized that the two iron-binding sites might serve different functions in iron transport. This was based on the observation that one portion of human or rabbit plasma transferrin radioiron was removed by rabbit reticulocytes more rapidly than another (4-6). It was proposed that this was a consequence of the preferential iron removal from one binding site by red cell precursors. In addition, it was proposed that the iron at the other binding site might be preferentially delivered to the liver. Since that time a number of publications have supported this hypothesis (literature cited in Refs. 1, 2, 19), but more direct observations employing two different iron isotopes to label selectively the two iron-binding sites, including a comparison of the two purified monoferric transferrin species, showed no behavioral difference between the two sites (12, (14) (15) (16) (17) 22) . In view of this discrepancy, it seemed appro riate to reexamine the reticulocyte incubation experiment that formed the cornerstone of the Fletcher-Huehns hypothesis.
MATERIALS AND METHODS
The observations employing human and rabbit plasma were carried out as described (4), except that iron-free plasma was prepared using deferoxamine (16 
RESULTS
During the initial incubation of human and rabbit test plasma with rabbit red blood cells (reticulocyte count 3l%), transferrin iron saturation fell from 40 to about 14%. Iron uptake from human transferrin was 0.85 t 0.2 pg/ml packed red cells per hour, so that incubation was continued for 90 min. In the homologous rabbit system, uptake was 1.94 t 0.2 pg/ml packed cells per hour, so that only 40 min were required.
After the preparatory incubation, plasma was separated from the reticulocytes by centrifugation (Fig. 1, level B test plasma). A "control plasma" was prepared by diluting the original labeled plasma with iron-free plasma and Hanks buffer (4). At this stage the total amount of iron radioactivity and transferrin was the same in each plasma. Then both plasmas were incubated with a similar number of reticulocytes, and the uptake of radioiron followed (Fig. 2) 1. Flow diagram of method for investigating availability of iron remaining in plasma after removal of some iron by reticulocytes. [Adapted from Fletcher (4) .] considerably higher uptake from the control plasma. These findings agree with the observation reported first by Fletcher and Huehns (5, 6).
The isoelectric focusing profiles of the human rat plasma, as well as the urea gel electrophoresis profiles of the rabbit plasma before and after preliminary incubation with reticulocytes, are shown in Fig. 3 . The plasmas at the initial saturation level displayed three radioiron peaks, identified as diferric and mono A and mono B transferrins. After incubation with reticulocytes, there was a disproportionate reduction in the amount of diferric transferrin with much less change in the relative amounts of the two monoferric species (Fig. 3, lower  portion) . This could be the consequence of either random or an "all-or-none" removal of iron from diferric transferrin. In the former case the two monoferric transferrins at the acid-stable or acid-labile site would be intermediates and would be present in identical amounts. In the latter instance, only apotransferrin should be found.
To distinguish between these two possibilites, 1251-diferric transferrin was employed, so that the amounts of mono-and apotransferrin formed could be monitored. Isoelectric focusing and urea gel electrophoresis showed about 90% of the 1251 to be in the position of apotransferrin, indicating a pairwise release of the two iron atoms from the transferrin molecule (Fig. 3, inset) .
The slower iron removal by reticulocytes in the Fletcher-Huehn hypothesis could then be explained if there was a differential rate of removal of iron from diferric compared with monoferric iron. To quantitate the molecular advantage, additional experiments were carried out employing purified human transferrin and rabbit reticulocytes. These mixtures of 55Fe-tagged diferric transferrin and 5gFe-tagged monoferric transferrin at equal iron concentrations (90 pg/dl) were incubated for 1 h with reticulocytes. The uptake of iron from various ratios of di-to monoferric human transferrin showed a consistent advantage of 6.9 t 1.0 (n = 6) for the diferric over the monoferric form (Table 1) . Experiments carried out with rabbit transferrin in the homologous rabbit system yielded an uptake advantage of 3.5 t 0.5 (n = 6) for the diferric form (data not shown).
DISCUSSION
Fletcher and Huehns (5, 6), from observations on a reticulocyte incubation system, proposed functional differences between the two iron-binding sites of transfer-R282 rin. The basic observation using rabbit reticulocytes as originally reported has been confirmed by a number of investigators, including the present report (1, 2, 19) .
However, the interpretation that iron from one binding site was preferentially taken up was inferential, and direct measurements of site behavior were not made. In this study and in two other reports using two isotopes to selectively label the two sites of transferrin, it has been shown that equal amounts of iron are taken up from the two sites by reticulocytes (7, 11, 12, 14, 15, 17, 20) .
Therefore one needed to look elsewhere for the discrepant behavior of transferrin iron during reticulocyte incubation. This explanation was found in the high competitive advantage of diferric transferrin over the mon-HUEBERS, HUEBERS, CSIBA, AND FINCH oferric form in the delivery of iron to reticulocytes (13). In a recreation of the original study, it was shown that both human and rabbit diferric transferrin in the plasma sample was markedly depleted during the preliminary incubation, leaving primarily monoferric transferrin for the second uptake study. By comparison, the diluted control plasma had a greater proportion of diferric transferrin. The conspicuous difference in the amount of iron taken up from the test and control plasma in the subsequent incubation was solely the result of differences in proportions of di-to monoferric transferrin in the two plasmas.
Although the differential behavior of di-and monoferric transferrin offers an explanation for many observations in the literature, it is clearly incompatible with some earlier reports (10, 21). In the first report, Harris and Aisen (10) incubated human and rabbit transferrin with rabbit reticulocytes as in the current paper. It was found that the delivery of iron from the two binding sites of human diferric transferrin showed heterogeneity (a 5- fold advantage of one over the other), whereas rabbit transferrin delivered iron from the two sites equally. They also found diferric and monoferric rabbit transferrins donated iron to reticulocytes at the same rate. On the other hand, a second report from the same laboratory (21) concluded that the two sites of iron in diferric rabbit transferrin were heterogenous (a > s-fold advantage of the N terminal site). Although the authors believed these results were more reliable than their earlier findings, subsequent reassessment by at least three different groups employing similar methodology showed identical rates of iron delivery from the two sites of rabbit diferric transferrin (7, 11, 17) . Delivery of iron from diferric transferrin has also been shown to be an all-or-none phenomenon, regardless of the mammalian species studied (14, 15, 17) .
phenomenon observed in vitro holds in vivo (12, 15, 17) . In other words, iron delivery from the two species of monoferric transferrin occurs at an identical rate, whereas delivery from diferric transferrin is also an allor-none phenomenon.
Furthermore, whereas the rate of delivery between diferric and monoferric transferrin differs, the iron distribution from diferric and the two species of monoferric transferrin to body tissues is identical (12, 15, 17) . These results hold for the two speciesof animals studied as well as for humans.
One may then conclude that the questions raised by Fletcher and Huehns (4-6) concerning the delivery of iron from the two sites of transferrin may be explained in both in vitro and in vivo systems by the different affinity of transferrin receptors for mono-and diferric transferrin. Some variability in the in vivo iron delivery from transferrin has also been reported (1, 2, 9, 17, 19) . However, in those studies that permit quantitative interpretation, it has been demonstrated that the same delivery Grant HL-06242 from the National This research was supported by Heart, Lung, and Blood Institute.
